Diagnostics & Research
The Diagnostics & Research industry has a total of 44 stocks, with a combined market cap of $873.21 billion, total revenue of $172.71 billion and a weighted average PE ratio of 48.27.
Market Cap
873.21B
Revenue
172.71B
Profits
18.09B
PE Ratio
48.27
Profit Margin
10.47%
Dividend Yield
0.20%
44 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 243.41B | 1.53% | 4,199,983 | 46.34B |
| 2 | DHR | Danaher Corporation | 149.38B | 1.99% | 6,179,160 | 25.11B |
| 3 | NTRA | Natera, Inc. | 52.80B | 6.07% | 2,560,729 | 2.71B |
| 4 | IQV | IQVIA Holdings Inc. | 44.35B | 0.23% | 1,714,582 | 16.98B |
| 5 | A | Agilent Technologies, Inc. | 44.08B | 1.72% | 2,893,909 | 7.37B |
| 6 | WAT | Waters Corporation | 42.22B | 2.65% | 688,819 | 4.64B |
| 7 | IDXX | IDEXX Laboratories, Inc. | 39.90B | -1.39% | 459,824 | 4.55B |
| 8 | ILMN | Illumina, Inc. | 37.02B | 7.10% | 3,676,675 | 4.49B |
| 9 | MTD | Mettler-Toledo International Inc. | 28.26B | 2.30% | 288,010 | 4.13B |
| 10 | DGX | Quest Diagnostics Incorporated | 27.31B | 0.15% | 989,490 | 11.56B |
| 11 | LH | Labcorp Holdings Inc. | 26.17B | -0.55% | 559,872 | 14.35B |
| 12 | GH | Guardant Health, Inc. | 24.57B | 4.69% | 1,858,422 | 1.18B |
| 13 | MEDP | Medpace Holdings, Inc. | 17.17B | -0.20% | 226,107 | 2.78B |
| 14 | RVTY | Revvity, Inc. | 16.37B | 0.69% | 2,753,779 | 2.91B |
| 15 | CRL | Charles River Laboratories International, Inc. | 13.45B | 3.02% | 809,837 | 4.00B |
| 16 | ICLR | ICON Public Limited Company | 13.09B | -2.45% | 1,172,012 | 8.29B |
| 17 | QGEN | Qiagen N.V. | 9.18B | 3.45% | 1,906,809 | 2.10B |
| 18 | RDNT | RadNet, Inc. | 6.12B | 2.64% | 573,219 | 2.27B |
| 19 | SHC | Sotera Health Company | 5.41B | -1.97% | 1,964,367 | 1.22B |
| 20 | BLLN | BillionToOne, Inc. | 5.22B | 6.81% | 547,229 | 397.41M |
| 21 | ADPT | Adaptive Biotechnologies Corporation | 4.56B | 3.18% | 3,279,603 | 308.08M |
| 22 | GRAL | GRAIL, Inc. | 3.57B | 6.44% | 1,529,324 | 165.26M |
| 23 | VCYT | Veracyte, Inc. | 3.26B | 5.38% | 1,470,326 | 561.90M |
| 24 | WGS | GeneDx Holdings Corp. | 3.13B | 7.73% | 827,130 | 454.43M |
| 25 | CDNA | CareDx, Inc. | 2.81B | 1.36% | 806,701 | 458.09M |
| 26 | NEO | NeoGenomics, Inc. | 2.56B | 5.02% | 2,006,839 | 766.30M |
| 27 | FRNM | Freenome, Inc. | 1.75B | 10.59% | 1,135,978 | 35.41M |
| 28 | PSNL | Personalis, Inc. | 1.73B | 0.74% | 5,649,397 | 69.67M |
| 29 | OPK | OPKO Health, Inc. | 1.21B | 0.62% | 1,710,348 | 587.90M |
| 30 | CSTL | Castle Biosciences, Inc. | 1.12B | 3.66% | 364,629 | 357.28M |
| 31 | FLGT | Fulgent Genetics, Inc. | 601.21M | 1.02% | 311,990 | 323.93M |
| 32 | MYGN | Myriad Genetics, Inc. | 395.99M | 7.25% | 2,830,702 | 806.60M |
| 33 | BDSX | Biodesix, Inc. | 303.98M | 0.88% | 60,842 | 102.94M |
| 34 | XGN | Exagen Inc. | 190.65M | 1.16% | 195,435 | 71.12M |
| 35 | BNR | Burning Rock Biotech Limited | 138.37M | 4.79% | 4,902 | 73.70M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 129.26M | 10.34% | 197,735 | 1.67M |
| 37 | QUCY | Quantum Cyber N.V. | 114.33M | 3.82% | 349,359 | 537.08K |
| 38 | MDXH | MDxHealth SA | 64.09M | -1.32% | 258,784 | 114.02M |
| 39 | PRPO | Precipio, Inc. | 47.33M | -0.83% | 406,718 | 27.20M |
| 40 | ADVB | Advanced Biomed Inc. | 12.09M | -5.18% | 34,056 | - |
| 41 | NDRA | ENDRA Life Sciences Inc. | 8.13M | 2.24% | 77,556 | - |
| 42 | XWEL | XWELL, Inc. | 7.77M | - | 27,368 | 28.28M |
| 43 | BIAF | bioAffinity Technologies, Inc. | 4.72M | 63.55% | 25,410,034 | 5.90M |
| 44 | ISPC | iSpecimen Inc. | 3.40M | -1.46% | 228,959 | 466.30K |